René A. J. Crans

Epigenetic silencing of triple negative breast cancer hallmarks by Withaferin A

Katarzyna Szarc vel Szic, Ken Declerck, René A. J. Crans et al. · Oncotarget · 2017 · 67 citations · Full text

Striatal Dopamine D2-Muscarinic Acetylcholine M1 Receptor–Receptor Interaction in a Model of Movement Disorders

René A. J. Crans, Elise Wouters, Marta Valle-León et al. · Frontiers in Pharmacology · 2020 · 26 citations · Full text

Synthesis toward Bivalent Ligands for the Dopamine D₂ and Metabotropic Glutamate 5 Receptors

Mingcheng Qian, Elise Wouters, James A. R. Dalton et al. · Journal of Medicinal Chemistry · 2018 · 23 citations · Full text

The mGlu5 Receptor Protomer-Mediated Dopamine D2 Receptor Trans-Inhibition Is Dependent on the Adenosine A2A Receptor Protomer: Implications for Parkinson’s Disease

Wilber Romero‐Fernandez, Jaume Taura, René A. J. Crans et al. · Molecular Neurobiology · 2022 · 14 citations · Full text

The validation of Short Interspersed Nuclear Elements (SINEs) as a RT-qPCR normalization strategy in a rodent model for temporal lobe epilepsy

René A. J. Crans, Jana Janssens, Sofie Daelemans et al. · PLoS ONE · 2019 · 13 citations · Full text